Are emerging PGD2 antagonists a promising therapy class for treating asthma?
a National Heart & Lung Institute , Imperial College , London , UK.
Hugo
H
Farne
a National Heart & Lung Institute , Imperial College , London , UK.
David J
DJ
Jackson
a National Heart & Lung Institute , Imperial College , London , UK.
Sebastian L
SL
Johnston
D018927:Anti-Asthmatic Agents / Q000494:pharmacology*; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D015195:Drug Design; D006801:Humans; D015230:Prostaglandin D2 / Q000037:antagonists & inhibitors* / Q000378:metabolism
D018927:Anti-Asthmatic Agents; D015230:Prostaglandin D2
Asthma; CRTH2 antagonists; DP2 receptor antagonists; prostaglandin D2